Cooper Investors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Cooper Investors’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-52,484	Closed	-$4.13M	–	37
2017 Q4	$4.13M	Sell	52,484 -141	-0.3%	-$11.7K	0.51%	34
2017 Q3	$4.86M	Sell	52,625 -1,375	-3%	-$132K	0.68%	32
2017 Q2	$6.11M	Buy	54,000 +14,284	+36%	+$1.6M	0.93%	31
2017 Q1	$3.98M	Buy	39,716 +10,676	+37%	+$1.14M	0.63%	35
2016 Q4	$3.12M	Buy	+29,040	New	+$3.4M	0.56%	35

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cooper Investors's CBPO Position: Q1 2018 in Review

Cooper Investors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2018, closing a stake of 52,484 shares — an estimated $4.13M sold.

Cooper Investors first reported a position in CBPO in Q4 2016 and held it in 5 quarters. The position peaked at $6.11M in Q2 2017. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2018.

Cooper Investors reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2018 after selling out during the quarter.
Cooper Investors sold 52,484 China Biologic Products Holdings, Inc. shares in Q1 2018, an estimated $4.13M.
Cooper Investors first reported a position in China Biologic Products Holdings, Inc. in Q4 2016 and held it in 5 quarters.
Cooper Investors's China Biologic Products Holdings, Inc. position peaked at $6.11M in Q2 2017.
86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2018.

Based on Cooper Investors's 13F filing for Q1 2018, filed 8 Apr 2025.